IRCT20190728044351N1
Recruiting
未知
Investigating the comparative effectiveness of biofeedback and auriculotherapy on menopoused women’s hot flashes referred to private clinics of gynecologists in Kerman city, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hot flashes.
- Sponsor
- Kerman University of Medical Sciences
- Enrollment
- 39
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •At least one year after menstruation
- •Hot flashes at least twice a day
- •Age 60\-45 years old
- •Willingness to participate in the research project and to complete the written consent form
- •Being Iranian
Exclusion Criteria
- •History of hysterectomy and ophorectomy
- •Hypertension and Cardiovascular Diseases, Thromboembolic, Thyroid Endocrine
- •Use of tobacco or alcohol
- •Abnormal vaginal bleeding
- •taking hormones and taking drugs that affect vasomotor symptoms
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Periodontal regeneration in infrabony defectsHealth Condition 1: K056- Periodontal disease, unspecifiedCTRI/2024/04/065200Sharad Pawar Dental College
Not yet recruiting
Not Applicable
A clinical trial to study the efficacy of two restorative materials, bioactive resin modified glass ionomer and resin modified glass ionomer in restoring occlusal cavity of primary molars.Health Condition 1: K025- Dental caries on pit and fissure surfaceCTRI/2023/09/057167Dr Revathi Murugan
Completed
Not Applicable
A clinical trial to study the effects of biologically based root canal procedures in periapically involved young immature permanent teethCTRI/2014/11/005197MM COLLEGE OF DENTAL SCIENCES AND RESEARCH30
Recruiting
Not Applicable
To Investigate predictors of the efficacies of biologics for rheumatoid arthritis or psoriatic arthritisRheumatoid arthritis, Psoriatic arthritisJPRN-UMIN000023152Immune-Mediated Diseases Therapy Center, Graduate School of Medicine University of Tokyo80
Recruiting
Not Applicable
Comparison study for the best use of the biologic agent in rheumatoid arthritis treatment with certolizumab pegol in the real worldRheumatoid ArthritisJPRN-UMIN000016340ORTHERN CAPITAL CLINIC30